Koyfin Home > Directory > Health Care > Adma Biologics > Total Assets

Adma Biologics Total Assets Chart (ADMA)

Adma Biologics annual/quarterly Total Assets from 2010 to 2020.
  • Adma Biologics Total Assets for the quarter ending June 06, 2020 was $192m a 28.07% increase of 54m year over year
  • Adma Biologics Total Assets for the last 12 months ending June 06, 2020 was $192m a 28.07% increase of 54m year over year
  • Adma Biologics Annual Total Assets for 2019 was $127m a 30.07% increase of 38m from 2018
  • Adma Biologics Annual Total Assets for 2018 was $89m a -21.54% decrease of -19m from 2017
  • Adma Biologics Annual Total Assets for 2017 was $108m a 78.07% increase of 84m from 2016
Other Balance Sheet Metrics:
  • Adma Biologics Other Liabilities for the quarter ending December 12, 2018 was $18m a -0.86% decrease of 0m year over year
  • Adma Biologics Total Equity for the quarter ending September 09, 2018 was $37m a -8.40% decrease of -3m year over year
View Chart On Koyfin

Quarterly ADMA Total Assets Data

06/2020$192m
03/2020$211m
12/2019$127m
09/2019$138m
06/2019$143m
03/2019$78m
12/2018$89m
09/2018$106m
06/2018$118m
03/2018$91m

Annual ADMA Total Assets Data

2019$127m
2018$89m
2017$108m
2016$24m
2015$24m
2014$27m
2013$32m
2012$16m
2011$3m
2010$5m